Latest Biotech News

Artificial intelligence continues deep integration into biotech workflows and clinical research. Advarra launched an AI and data-driven protocol optimization tool, Study Design, leveraging...

Progress in metabolic and rare disease therapeutics is marked by several clinical updates. MBX Biosciences announced positive phase II data for canvuparatide in chronic hypoparathyroidism,...

Innovative research in stem cell-derived models and neurotechnology advances understanding and treatment of neurological disorders. Johns Hopkins University demonstrated AI-enabled detection of...

Pfizer has made a major move to re-enter the obesity drug market by agreeing to acquire Metsera for up to $7.3 billion, including contingencies based on clinical and regulatory milestones....

The U.S. FDA has approved Merck's Keytruda Qlex, the first subcutaneous injection formulation of its blockbuster anti-PD-1 immunotherapy. This new product enables administration in about a minute...

Ionis Pharmaceuticals reported positive pivotal Phase 3 trial results for zilganersen, an antisense oligonucleotide aimed at treating Alexander disease, a rare neurogenetic disorder. The drug...

Artificial intelligence applications continue to expand in biotech, addressing challenges from open-access publishing to clinical research design. Researchers developed an AI platform capable of...

MapLight Therapeutics, a biotech focused on neurological diseases, has filed for an initial public offering to list on Nasdaq under 'MPLT.' The company is advancing its lead drug candidate...

Stealth Biotherapeutics received FDA accelerated approval for its drug elamipretide (Forzinity) to improve muscle strength in patients with Barth syndrome, a rare pediatric mitochondrial disease....

MBX Biosciences announced positive top-line Phase II study results for canvuparatide in treating chronic hypoparathyroidism, achieving the trial’s primary endpoint. The drug demonstrated...

Eli Lilly has partnered with Lila Bio, a pioneer in AI-enabled protein design, to co-develop radioligand therapies targeting solid tumors. Using Lila’s AI and machine learning platforms, the...

PacBio has expanded into high-throughput carrier screening with a new suite of PureTarget panels leveraging its highly accurate HiFi long-read sequencing technology. These panels consolidate...

Pfizer has announced its acquisition of Metsera for an initial $4.9 billion upfront payment, aiming to strengthen its position in the obesity drug market. The deal includes contingent milestone...

Recent advances demonstrate significant integration of AI and machine learning into various facets of biotech, from disease diagnostics to drug discovery. Researchers at Johns Hopkins University...

The FDA has advanced multiple significant approvals impacting biotech therapeutics and diagnostics. Merck’s Keytruda received clearance for a rapid subcutaneous injection formulation, enabling...

Biotech researchers have introduced cutting-edge gene editing advances to refine control over gene expression and enhance therapeutic potential. Korean scientists developed a dual-mode CRISPR...

Several biotech firms reported pivotal progress in therapeutic development targeting rare diseases and cancers. Ionis Pharmaceuticals announced positive top-line results in a phase 3 trial for...

Advances in diagnostic testing are poised to transform disease detection and patient monitoring. Phase Scientific launched a large-scale clinical study of its urine-based HPV test aimed at...

The biotech and pharmaceutical industries are experiencing significant workforce reductions. Six major pharma companies—including Novo Nordisk, Merck, Bayer, Bristol Myers Squibb, Pfizer, and...

Recent studies have uncovered crucial cellular processes and chemical pathways relevant to disease mechanisms and treatment opportunities. Researchers revealed lipids' role in activating...